Handelsbanken Fonder
TARS icon

Handelsbanken Fonder’s Tarsus Pharmaceuticals TARS Stock Holding History

Handelsbanken Fonder’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$944K Buy
15,000
+1,200
+9% +$76.7K ﹤0.01% 1167
2026
Q1 		$968K Hold
13,800
– – ﹤0.01% 1057
2025
Q4 		$1.13M Buy
+13,800
New +$1.03M ﹤0.01% 984

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Handelsbanken Fonder's TARS Position: Q2 2026 in Review

Handelsbanken Fonder increased its Tarsus Pharmaceuticals (TARS) stake by 8.7% in Q2 2026, buying an estimated $76.7K and bringing the position to 15,000 shares worth $944K. The position accounts for ﹤0.01% of the portfolio, ranked #1167.

Handelsbanken Fonder first reported a position in TARS in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.13M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Handelsbanken Fonder held 15,000 shares of Tarsus Pharmaceuticals worth $944K as of Q2 2026.
  • Handelsbanken Fonder bought 1,200 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $76.7K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1167 holding.
  • Handelsbanken Fonder first reported a position in Tarsus Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Handelsbanken Fonder's Tarsus Pharmaceuticals position peaked at $1.13M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.